Page last updated: 2024-08-17

dehydroepiandrosterone and oxyntomodulin

dehydroepiandrosterone has been researched along with oxyntomodulin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Liu, AH; Shen, HF; Tao, ZB; Wang, LY; Wang, YF; Wang, YQ; Wang, YX; Wu, LM; Zhan, Y	1

Other Studies

1 other study(ies) available for dehydroepiandrosterone and oxyntomodulin

Article	Year
Dulaglutide, a long-acting GLP-1 receptor agonist, can improve hyperandrogenemia and ovarian function in DHEA-induced PCOS rats. Peptides, 2021, Volume: 145 Topics: Animals; Body Weight; Dehydroepiandrosterone; Disease Models, Animal; Female; Gene Expression Regulation; Glucagon-Like Peptide-1 Receptor; Glucagon-Like Peptides; Immunoglobulin Fc Fragments; Insulin Resistance; Ovary; Ovulation; Phosphoproteins; Polycystic Ovary Syndrome; Rats, Sprague-Dawley; Recombinant Fusion Proteins; Sex Hormone-Binding Globulin; Steroid 17-alpha-Hydroxylase; Testosterone	2021

Article

Year

Dulaglutide, a long-acting GLP-1 receptor agonist, can improve hyperandrogenemia and ovarian function in DHEA-induced PCOS rats.

Peptides, 2021, Volume: 145

Topics: Animals; Body Weight; Dehydroepiandrosterone; Disease Models, Animal; Female; Gene Expression Regulation; Glucagon-Like Peptide-1 Receptor; Glucagon-Like Peptides; Immunoglobulin Fc Fragments; Insulin Resistance; Ovary; Ovulation; Phosphoproteins; Polycystic Ovary Syndrome; Rats, Sprague-Dawley; Recombinant Fusion Proteins; Sex Hormone-Binding Globulin; Steroid 17-alpha-Hydroxylase; Testosterone

2021